Interestingly, higher proportion of patients with late stages of HNSCC (T3 and T4) belonged to the “high” Jagged2 and Hey1 populations as compared to patients with low stages of HNSCC that mostly expressed low or intermediate levels of these proteins (Fig. 5b, Supplementary data 7). This evidence concerns the gene HEY1 and head and neck squamous cell carcinoma.